Detalles de la búsqueda
1.
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
Eur J Haematol
; 98(3): 280-288, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859648
2.
Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.
Eur J Haematol
; 96(1): 19-26, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691036
3.
Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study.
Haematologica
; 98(7): 1045-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23585526
4.
Importance of optimal dosing ≥ 30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with ß-thalassaemia.
Eur J Haematol
; 87(4): 355-65, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21668502
Resultados
1 -
4
de 4
1
Próxima >
>>